Visits: 496, Avg visit time (secs): 123,49 Back to Index
| Page | Hits | Percent |
|---|---|---|
| 207 | 41,73% | |
| /sanofi-aventis/contact.html | 47 | 9,48% |
| /sanofi-aventis/home.html | 42 | 8,47% |
| /sanofi-aventis/programmes.html | 24 | 4,84% |
| /sanofi-aventis/reviewers.html | 20 | 4,03% |
| /sanofi-aventis/partners.html | 20 | 4,03% |
| /sanofi-aventis/recipients.html | 11 | 2,22% |
| /sanofi-aventis/reports.html | 10 | 2,02% |
| /sanofi-aventis/endocannabinoid/efsd-sanofi-aventis-ecs-recipients.html | 9 | 1,81% |
| /sanofi-aventis/micro_macro/recipientsmicro_macro.html | 9 | 1,81% |
| /efsd-jdrf-novo/efsd-jdrf-novo-t1-recipients.html | 5 | 1,01% |
| Page | Hits | Percent |
|---|---|---|
| /exit.htm | 230 | 46,37% |
| /sanofi-aventis/home.html | 52 | 10,48% |
| /sanofi-aventis/programmes.html | 51 | 10,28% |
| /sanofi-aventis/partners.html | 31 | 6,25% |
| /sanofi-aventis/recipients.html | 19 | 3,83% |
| /sanofi-aventis/reviewers.html | 14 | 2,82% |
| /sanofi-aventis/contact.html | 9 | 1,81% |
| /sanofi-aventis/macrovascular/efsd-sanofi-aventis-cvd-recipients.html | 4 | 0,81% |
| /sanofi-aventis/reports.html | 4 | 0,81% |
| /sanofi-aventis/executive.html | 3 | 0,60% |
| /new_horizons/new-horizons11.html | 3 | 0,60% |